Pdt Partners, LLC Relay Therapeutics, Inc. Call Options Transaction History
Pdt Partners, LLC
- $1.01 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$63.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$48.4 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$44.9 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $784M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...